An elevation of ALAT or ASAT transaminases in a pediatric assessment does not automatically indicate a serious liver disease. However, pediatrics requires a different interpretation framework than that of adults, with age-specific thresholds, specific etiologies, and warning signals that necessitate a rapid response.
ASAT/ALAT Ratio in Children: A Kinetics That Guides Diagnosis
In infants, the ASAT/ALAT ratio is physiologically greater than 1, as muscle and erythrocyte-derived ASAT contribute more significantly to the enzymatic assessment. This ratio gradually reverses with growth, approaching the adult profile by adolescence.
Further reading : Everything You Need to Know About Season 2 of Darling in the Franxx: Release Date and New Characters
Interpreting hepatic cytolysis without considering this ratio can lead to errors. An isolated elevation of ASAT in an infant initially suggests an extra-hepatic origin (hemolysis, muscle damage, macro-ASAT) before suspecting the liver. ALAT, which is more specific to liver tissue, remains the preferred marker to confirm hepatocyte distress.
We systematically recommend coupling the measurement of transaminases with CPK, LDH, and haptoglobin when the elevation primarily concerns ASAT. Understanding the norms for elevated transaminases in children first requires mastering these physiological particularities related to age.
See also : Everything You Need to Know About the Release Date of Darling in the Franxx Season 2
Another common pitfall: intense physical exercise. An athletic adolescent may present with moderately elevated ASAT and ALAT after intense training, without any liver damage. A follow-up assessment after several days of rest can clarify the situation.
Acute Cytolysis in Children: Alert Thresholds and Severity Signals
An elevation of transaminases exceeding several times the upper limit of normal necessitates an urgent diagnostic approach. In pediatrics, the tolerance for significant cytolysis should be lower than in adults, as certain pediatric liver diseases can rapidly progress to acute liver failure.
Since 2022, Santé publique France has reported a resurgence of severe acute hepatitis of undetermined origin in children, with some forms being fulminant and requiring liver transplantation. This epidemiological context has heightened the level of vigilance in routine pediatric practice.
The signals that warrant an urgent consultation include:
- A rapidly appearing jaundice associated with significant cytolysis, especially if the child shows a deterioration in general condition (unusual drowsiness, prolonged refusal to eat)
- Coagulation disorders (decreased TP, collapsed factor V) accompanying the elevation of transaminases, as they indicate early hepatic cell failure
- Painful hepatomegaly with persistent fever, which may suggest acute viral hepatitis, macrophage activation syndrome, or tumor infiltration
- A concurrent elevation of ALAT, PAL, and conjugated bilirubin, indicating an associated cholestasis that alters management
The measurement of factor V is the key marker of severity in any pediatric acute cytolysis. A collapsed level in the context of hypertransaminasemia constitutes an indication for transfer to a specialized liver center.
Moderately Elevated Transaminases in Adolescents: Hepatic Steatosis and Metabolic Causes
Moderate chronic hypertransaminasemia in adolescents is no longer solely attributed to viral hepatitis. Hepatic steatosis associated with metabolic dysfunction (formerly NAFLD, now renamed MASLD) has become a frequent cause of persistent ALAT elevation in this age group.
The increase in the prevalence of pediatric obesity has mechanically raised the number of adolescents presenting with steatosis on ultrasound, associated with moderately elevated ALAT. A chronic elevation of ALAT in an overweight adolescent should prompt a search for a complete metabolic syndrome (waist circumference, fasting blood glucose, triglycerides, HDL cholesterol).
The difficulty lies in the fact that steatosis can coexist with another cause of liver disease. We regularly observe liver assessments that are too quickly attributed solely to excess weight, while an underlying autoimmune hepatitis or Wilson’s disease has not been excluded.
When to Deepen the Liver Assessment
A persistent elevation of ALAT beyond several months despite hygienic-dietary measures justifies a complete etiological assessment. This assessment includes at least serologies for hepatitis B and C, measurement of ceruloplasmin (screening for Wilson’s disease, which can only be diagnosed in pediatrics in its early forms), anti-smooth muscle and anti-LKM1 antibodies (autoimmune hepatitis), as well as a martial assessment (serum iron, ferritin, transferrin saturation coefficient).
Wilson’s disease remains the diagnosis that must never be missed in a child or adolescent with unexplained cytolysis. Its early treatment radically alters the prognosis.
Hepatotoxic Medications in Pediatrics: Monitor Transaminases During Treatment
Some medications commonly prescribed in pediatrics require regular monitoring of transaminases. Antiepileptics (particularly valproic acid), certain long-term antibiotics, and immunosuppressive treatments are among the main iatrogenic causes of elevated ALAT in children.
Valproic acid deserves specific attention: its hepatotoxicity, although rare, can be fulminant in young children, especially under two years old and in cases of polytherapy for epilepsy. Any elevation of transaminases while on valproic acid requires close monitoring and reevaluation of treatment.
In adolescents, the question of dietary supplements and bodybuilding products is increasingly relevant. Some of these products contain undeclared hepatotoxic substances. A thorough inquiry about medication and para-medication use is an integral part of the assessment of any unexplained hypertransaminasemia.
The approach to elevated transaminases in children thus depends as much on the clinical context as on the level of elevation. An acute cytolysis with signs of severity requires urgent hepatological intervention. A persistent moderate elevation necessitates a methodical etiological assessment, without settling for a diagnosis of exclusion. In both cases, the pediatric specificity of hepatic metabolism necessitates not applying adult reasoning.